General Information of the Compound
| Compound ID |
CP0390318
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(3-acetamidophenyl)-3-chlorobenzamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
3-chloro-N-(3-acetamidophenyl)benzamide
312632-92-1
AB00088853-01
AC1LDLQ1
AC1Q1KO6
AKOS001296542
BDBM50312136
CHEBI:93070
CHEMBL1080810
Cambridge id 5554516
EU-0002463
MCULE-8869105852
MLS002699912
MolPort-001-508-240
N-(3-acetamidophenyl)-3-chlorobenzamide
N-[3-(acetylamino)phenyl]-3-chlorobenzamide
N-{3-[(3-chlorophenyl)carbonylamino]phenyl}acetamide
Oprea1_130541
Oprea1_356143
SMR001530668
SR-01000407944
SR-01000407944-1
ST042764
STK036460
Z28281866
ZINC29723
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H13ClN2O2
|
||||||||||||||||||
| Molecular Weight |
288.734
|
||||||||||||||||||
| Canonical SMILES |
CC(=O)Nc1cccc(NC(=O)c2cccc(Cl)c2)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H13ClN2O2/c1-10(19)17-13-6-3-7-14(9-13)18-15(20)11-4-2-5-12(16)8-11/h2-9H,1H3,(H,17,19)(H,18,20)
Show/Hide
|
||||||||||||||||||
| InChIKey |
XZMOBKLRYXTSSS-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound